Additional Breast Screening Methods May Benefit High-Risk Women (04-11-2012)
Screening high-risk women with ultrasound or MRI in addition to mammography resulted in a higher rate of cancer detection, but also increased false-positive results, according to the results of a study published in the Journal of the American Medical... Continue Reading
Study Compares Two Types of BCG for Bladder Cancer (04-10-2012)
For non-muscle-invasive bladder cancer, use of theConnaughtstrain of bacillus Calmette-Guérin (BCG) may be more effective at preventing recurrences than the Tice strain of BCG. These results—from a Phase III clinical trial—were presented at the 2012... Continue Reading
Pregnancy After Breast Cancer Appears to Be Safe (04-2-2012)
A study of young women found that pregnancy after a diagnosis of estrogen receptor-positive breast cancer does not appear to increase the risk of cancer recurrence. These results were presented at the eighth European Breast Cancer Conference.
Breast cancer... Continue Reading
Study Explores Non-Drug Treatments for Menopausal Symptoms (03-27-2012)
Exercise and cognitive behavioral therapy may reduce menopausal symptoms among young women who have been treated for breast cancer. These results were presented at the eighth European Breast Cancer Conference (EBCC-8).
For women with breast cancer, treatments... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (03-26-2012)
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet.
A growing body of evidence suggests that aspirin may reduce... Continue Reading
Dense Breasts May Increase Risk of Breast Cancer Recurrence (03-23-2012)
Among women over the age of 50 who have been diagnosed with breast cancer, those with high breast density may be more likely to have a recurrence of their breast cancer. These results were presented at the eighth European Breast Cancer Conference (EBCC-8).
Breast... Continue Reading
Almost 800,000 Lung Cancer Deaths Prevented (03-22-2012)
Changes in smoking behavior that began in the 1950s prevented close to 800,000 lung cancer deaths between 1975 and 2000. These results were published in the Journal of the National Cancer Institute.
Lung cancer remains the leading cause of cancer death... Continue Reading
Combination of Herceptin and Tykerb May Provide Breast Cancer Benefit (03-20-2012)
For the neoadjuvant (before surgery) treatment of HER2-positive breast cancer, a combination of Herceptin® (trastuzumab) and Tykerb® (lapatinib) may be more effective than either drug alone. These results were published in The Lancet.
Approximately... Continue Reading
Zelboraf Improves Melanoma Survival (03-16-2012)
Among patients with previously treated metastatic melanoma that carries a certain gene mutation, the targeted drug Zelboraf® (vemurafenib) resulted in a median overall survival of 16 months. This is a substantial improvement over what has been seen in... Continue Reading
Lymphoma During Pregnancy Can Have Good Outcomes (03-14-2012)
Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good. This was true for women who began lymphoma treatment during the second or third trimester of pregnancy, as well as women who deferred treatment... Continue Reading
Estrogen Alone May Reduce Breast Cancer Risk (03-12-2012)
Postmenopausal women who take hormone therapy consisting of estrogen alone may have a reduced risk of developing or dying from breast cancer. These findings—from longer-term follow-up of the Women’s Health Initiative trial of estrogen alone—were... Continue Reading
Tamoxifen Benefits Subset of Women with DCIS (03-9-2012)
Among women who have estrogen receptor-positive ductal carcinoma in situ (DCIS) of the breast, adjuvant (post-surgery) treatment with tamoxifen may reduce the risk of subsequent breast cancer. These results were published in the Journal of Clinical Oncology.
DCIS... Continue Reading